Retention of viral infectivity after extensive mutation of the highly conserved immunodominant domain of the feline immunodeficiency virus envelope

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4339-4346

  Pancino, Gianfranco ^a   Sonigo, Pierre ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; MOLECULAR CLONING; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; VIRUS ENVELOPE; VIRUS INFECTIVITY;

EID: 0030992892     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4339-4346.1997     Document Type: Article

References (34)

1. Avraméas, A., A. D. Strosberg, A. Moraillon, P. Sonigo, and G. Pancino. 1993. Serological diagnosis of feline immunodeficiency virus (FIV) infection based on synthetic peptides from Env glycoproteins. Res. Virol. 144:209-218.
2. Bertoni, G., M.-L. Zahno, R. Zanoni, H.-R. Vogt, E. Peterhans, G. Ruff, W. P. Cheevers, P. Sonigo, and G. Pancino. 1994. Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane protein associates with the development of arthritis. J. Virol. 68:7139-7147.
3. Cao, J., L. Bergeron, E. Helseth, M. Thali, H. Repke, and J. Sodroski. 1993. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:2747-2755.
4. Chong, Y.-H., J. M. Ball, C. J. Issel, R. C. Montelaro, and K. E. Rushlow. 1991. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus. J. Virol. 65:1013-1018.
5. Dedera, D., R. Gu, and L. Ratner. 1992. Conserved cysteine residues in the human immunodeficiency virus type 1 transmembrane envelope protein are essential for precursor envelope cleavage. J. Virol. 66:1207-1209.
6. Dubay, J. W., S. J. Roberts, B. H. Hahn, and E. Hunter. 1992. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66:6616-6625.
7. Eaton, A. M., K. E. Ugen, D. B. Weiner, T. Wildes, and J. A. Levy. 1994. An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement. AIDS Res. Hum. Retroviruses 10:13-18.
8. Fontenot, J. D., E. A. Hoover, J. H. Elder, and R. C. Montelaro. 1992. Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis. J. Clin. Microbiol. 30:1885-1890.
9. Gallaher, W. R., J. M. Ball, R. F. Barry, M. C. Griffin, and R. C. Montelaro. 1989. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5:431-440.
10. Gnann, J. W., J. B. McCormick, S. Mitchell, J. A. Nelson, and M. B. A. Oldstone. 1987. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science 237:1346-1349.
11. Goff, S., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
12. Heath, S. L., J. Grant, J. G. Tew, A. K. Szakal, and G. F. Burton. 1995. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377:740-744.
13. Hunter, E., and R. Swanstrom. 1990. Retrovirus envelope glycoproteins, p. 187-253. In R. Swanstrom and P. K. Vogt (ed.), Retroviruses. Strategies of replication. Springer-Verlag, Berlin, Germany.
14. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
15. Mascola, J. R., B. J. Mathieson, P. M. Zack, M. C. Walker, S. B. Halstead, and D. S. Burke. 1993. Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res. Hum. Retroviruses 9:1175-1184.
16. Moraillon, A., F. Barre-Sinoussi, A. Parodi, R. Moraillon, and C. Dauguet. 1992. In vitro properties and experimental pathogenic effect of three feline immunodeficiency viruses (FIV) isolated from cats with terminal disease. Vet. Microhiol. 31:41-54.
17. Moraillon, A. Personal communication.
18. Norrby, E., G. Biberfeld, F. Chiodi, A. von Gegerfeldt, A. Nauclér, E. Parks, and R. Lerner. 1987. Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature 329:248-250.
19. Norrby, E., G. Biberfeld, P. R. Johnson, D. E. Parks, R. A. Houghten, and R. A. Lerner. 1989. The chemistry of site-directed serology for HIV infections. AIDS Res. Hum. Retroviruses 5:487-493.
20. Oldstone, M. B. A., A. Tishon, H. Lewicki, H. J. Dyson, V. A. Feher, N. Assa-Munt, and P. E. Wright. 1991. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy. J. Virol. 65:1727-1734.
21. Osborne, R., M. Rigby, K. Siebelink, J. C. Neil, and O. Jarrett. 1994. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J. Gen. Virol. 75:3641-3645.
22. Pancino, G., L. Camoin, and P. Sonigo. 1995. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J. Virol. 69:2110-2118.
23. Pancino, G., S. Castelot, and P. Sonigo. 1995. Differences in feline immunodeficiency virus (FIV) host cell range correlate with envelope fusogenic properties. Virology 206:796-806.
24. Pancino, G., C. Chappey, W. Saurin, and P. Sonigo. 1993. B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins. J. Virol. 67:664-672.
25. Robinson, W. E., Jr., M. K. Gorny, J.-Y. Xu, W. M. Mitchell, and S. Zolla-Pazner. 1991. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. J. Virol. 65:4169-4176.
26. Robinson, W. E., Jr., T. Kawamura, D. Lake, Y. Masuho, W. M. Mitchell, and E. M. Hersh, 1990. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J. Virol. 64:5301-5305.
27. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
28. Sattentau, Q. J., S. Zolla-Pazner, and P. Poignard. 1995. Epitope exposure on functional, oligomeric HIV-1 gp41 molecules. Virology 206:713-717.
29. Schulz, T. F., B. A. Jameson, L. Lopalco, A. G. Siccardi, R. A. Weiss, and J. P. Moore. 1992. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? AIDS Res. Hum. Retroviruses 8:1571-1580.
30. Sibille, P., A. Avraméas, A. Moraillon, J. Richardson, P. Sonigo, G. Pancino, and A. D. Strosberg. 1995. Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats. Vet. Microbiol. 45:259-267.
31. Syu, W.-J., W.-R. Lee, B. Du, Q.-C. Yu, M. Essex, and T.-H. Lee. 1991. Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. J. Virol. 65:6349-6352.
32. Talbott, R. L., E. E. Sparger, K. M. Lovelace, W. M. Fitch, N. C. Pedersen, P. A. Luciw, and J. H. Elder. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:5743-5747.
33. Unger, R. E., M. L. Marthas, A. A. Lackner, E. Pratt-Lowe, B. L. Lohman, K. Van Rompay, and P. A. Luciw. 1992. Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. J. Med. Primatol. 21:74-81.
34. Zhang, H., Y. Zhang, T. Spicer, D. Henrard, and B. J. Poiesz. 1995. Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle. J. Virol. 69:3675-3682.